周源

周源，女，1966年8月生，生物醫學博士、資深科學家，技術總監。 ^[1] 

1990年從北京醫科大學畢業以後，在北京首都醫科大學附屬宣武醫院臨牀免疫科工作3年。 ^[2] 

1994年赴美攻讀博士學位。主攻生長激素在體內外細胞生物學信號傳導。1998年獲博士學位。 ^[3] 

1998年至2001年，在美國life technology生命技術公司產品研發部門工作. 歷任助理科學家，科學家，資深科學家,產品研發部經理. ^[4] 

2001年至2005年,就職於Eurogentec美國分部，領導抗體的研發和市場化管理。

2007年至2010年，就職於美國Amunix醫藥公司任臨牀醫藥產品開發部高級經理，參與研製治療兒童侏儒症的長效生長激素藥品VRS-317，其衍生公司VERSARTIS 於2014年3月在NASDAQ 成功上市 (NASDAQ: VSAR)。 ^[5] 

2010年，創立美國AbboMax生物醫藥公司，從事並領導相關醫藥產品的科研和臨牀應用產業化。 ^[6] 

教育程度:

1990年，中國北京醫科大學基礎醫學專業，醫學學士。

1998年，美國賓夕法尼亞州立大學生物醫學專業，博士。

美國細胞生物學協會會員（ASCB #38985）

美國癌症研究協會資深會員 （AACR#110600）

美國科學促進協會會員（AAAS #12817503）

1998年,美國USDA科學基金

(TheUSDAGrantreward, Graduate Student Program atthe Penn State Univ. Title: The signaling of chronic administration of growthhormone in vivo).

1994年,北京市科技進步獎二等獎

(TheSecond Prize of Science and Technology Improvement, awarded by Beijing HealthBureau, 1994: Title: Detection of anti-double-stranded DNA (ds-DNA)antibodies by Polymerase Chain Reaction (PCR) Method).

1993年, 北京市科技進步獎二等獎

(TheSecond Prize of Science and Technology Improvement, awarded by Beijing HealthBureau, 1993: Title: A fast, sensitive ELISA method for detecting hiddenrheumatoid factors (hRF) in the patients with autoimmune disease).

延長並維持近期發現的有治療功用的蛋白質在急性T淋巴白血病治療中的生物活性（Prolong thebiological activity of the recently discovered potential protein in TALL patients (in Preparation)）. ^[7] 

·HongWang, Charles Owens, Nidhi Chandra, Mark R. Conaway, David L. Brautigan, andDan Theodorescu (2010), Phosphorylationof RalB is important for bladder cancer cell growth and metastasis. CancerRes. 70(21):8760-9. ^[8] 

·ClaudiaP. Hernandez, Kevin Morrow, Lluis A. Lopez-Barcons, Jovanny Zabaleta, RosaSierra, Cruz Velasco, John Cole, and Paulo C. Rodriguez (2010). Pegylated arginase I: a potentialtherapeutic approach in T-ALL. Blood.115(25): 5214–5221. ^[7] 

·ZhouYuan, Xin Wang, Hongzhi Liu (2008), A Novel Method of Developing aHigh-Affinity Monoclonal Antibodies to Capture Native or Pegylated HumanGranulocyte Colony-Stimulating Factor (G-CSF), Proceedings of the 99th AnnualMeeting of the American Association for Cancer Research; 2008 Apr 12-16. ^[9] 

·ZhouY.Xu, H etal (2006) Midkine, Apotential Tumor Biomarker is Enhanced in Huh7 And HepG2 Human Hepatoma Cells. Proceedings of the 46thAnnual Meeting of the American Society for Cell Biology; 2006; December 9-13. ^[10] 

·ZhouY.WangX, Hadley J,CoreySJ,Vasilatos-Younken R (2005) Regulation of JAK2 protein expressionby chronic, pulsatile GH administration in vivo: a possible mechanism forligand enhancement of signal transduction.Gen Comp Endocrinol. 144(2): 128. ^[11] 

·Zhou Y. SungJ,HongA(2005) The enhancement of serine/threonine kinaseactivity is associated with the p53-PUMA apoptotic pathway. Proceeding of the AmericanAssociation for Cancer Research. Volume 46(S): 1286.

·ZhouY,CeciliaPo,VeronicaWei,AnitaHong,Yun-JuanChoi,Lindy Kauffman (2004) A Study of Fluorophore Labeled Cell-Permeable Peptides inCancer Research.ProcAmerAssocCancer Research, 45(s): 1011.

·Zhou Y. Sung J, Po C, Hong A, Zhihe Liu, Chien-an Andy Hu,(2004) Phosphorylation of PUMA isAssociated with Apoptotic induced Leukemia Cells, Mol Bio Cell, 15(s):737.

·Zhou Y, SungJ, Hong, A, (2003) The development and application of monoclonal antibodies tophospherine and phosphothreonine. MolBio Cell, 14(s): 154.

·Zhou Y, Sung J, Hong, A,Chen,K,ShihJC,Cases O,VitalisT(2003) A New Tool to RevealTrace amine signaling pathway: An antibody to b-phenethylamine. MolBio Cell, 14(s): 128.

·Hong, A,Zhou,Y.Diwu, Z.(2003) Phosphopeptides and their biological applications.CHIMICAOGGI,Chemistry today. June 2003, 57.

·Vasilatos-Younken R, Zhou Y, Wang XH, McMurtry JP,Rosebrough RW, Decuypere E, Buys N, Darras V, Geyten SVD and Tomas F (2000)Altered thyroid hormone metabolism with chronic growth hormone (GH) enhacement in vivo: Consequences for skeletalmuscle growth.J.Endocrinol. 166(3): 609.

·Wang XH, Zhou Y, Day JR, Beard JL, Vasilatos-Younken R.(2000) Evidence of a role for neuropeptide Y and monoamines in mediating theappetite-suppressive effect of GH. J Endocrinol. 166(3): 621-630.

·Ashwell CM, McMurtry JP, Wang XH, Zhou Y,Vasilatos-Younken R (1999) Effects of growth hormone and pair-feeding on leptinmRNA expression in liver and adipose tissue. DomestAnimEndocrinol.17(1): 77.

·Zhou Y,WangXH, McMurtry JP, Vasilatos-YounkenR (1998) Induction and activation of JAK2 protein occur with chronic exposureto GH, despite lack of an anabolic response in chicken skeletal muscle. J PoultSci 77(1): 33.

·Vasilatos-Younken R, Wang XH, Zhou Y, Day JR, McMurtryJP, Rosebrough RW, Decuypere E, Buys N, Darras V, Beard JL, Tomas F (1999) Newinsight into the mechanism and actions of growth hormone (GH) in poultry.DomestAnimEndocrinol. 17 (2-3), 181-190, Review.

·YuNai-ChangandZhouYuan(1998) Detection of anti-double-stranded DNA (ds-DNA) antibodies by PCRmethod. Chinese Journal of Immunology,14(1): 43。

·餘乃昌，徐陸亭 ，周源，等。應用PCR技術檢測血清抗雙鏈DNA抗體。中國免疫學雜誌. 1998年01期 ^[12] 

·劉恕，劉桂榮，周源，等. .隱性類風濕因子的測定方法及臨牀意義.中華內科雜誌，1993，32:531-533